We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
-2.23%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$420M
AUM Growth
-$4.4M
Cap. Flow
-$4.21M
Cap. Flow %
-1%
Top 10 Hldgs %
77.15%
Holding
64
New
2
Increased
1
Reduced
25
Closed
2

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.02M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$215K
3
PFE icon
Pfizer
PFE
+$3.34K

Top Sells

Rank Stock Value
1
CHK
Chesapeake Energy Corporation
CHK
+$904K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$890K
3
BP icon
BP
BP
+$395K
4
TPR icon
Tapestry
TPR
+$372K
5
MRK icon
Merck
MRK
+$326K

Sector Composition

Rank Sector Weight
1 Financials 37.76%
2 Energy 17.62%
3 Healthcare 11.25%
4 Consumer Discretionary 9.91%
5 Materials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
26
Lowe's Companies
LOW
$119B
$2.12M 0.51%
30,795
– –
MTB icon
27
M&T Bank
MTB
$34.9B
$1.88M 0.45%
15,000
– –
SU icon
28
Suncor Energy
SU
$77.1B
$1.57M 0.37%
49,330
-950
-2% -$28.2K
DD
29
DELISTED
Du Pont De Nemours E I
DD
$1.35M 0.32%
19,254
– –
KMI icon
30
Kinder Morgan
KMI
$71.6B
$1.06M 0.25%
25,150
– –
HON icon
31
Honeywell
HON
$69.5B
$1.05M 0.25%
11,658
– –
PFE icon
32
Pfizer
PFE
$162B
$1.04M 0.25%
35,257
+105
+0.3% +$3.34K
LPX icon
33
Louisiana-Pacific
LPX
$5.03B
$1.03M 0.25%
62,150
– –
GSK icon
34
GSK
GSK
$103B
$949K 0.23%
+17,764
New +$1.02M
PG icon
35
Procter & Gamble
PG
$337B
$908K 0.22%
9,970
– –
JPM icon
36
JPMorgan Chase
JPM
$950B
$861K 0.21%
13,766
-1,000
-7% -$59.2K
CPB icon
37
Campbell Soup
CPB
$6.96B
$853K 0.2%
19,375
– –
IBKC
38
DELISTED
IBERIABANK Corp
IBKC
$841K 0.2%
12,972
– –
ZBH icon
39
Zimmer Biomet
ZBH
$19.3B
$742K 0.18%
6,736
-206
-3% -$23.5K
ITW icon
40
Illinois Tool Works
ITW
$81.1B
$627K 0.15%
6,625
– –
T icon
41
AT&T
T
$177B
$553K 0.13%
21,782
– –
HK
42
DELISTED
Halcon Resources Corporation
HK
$537K 0.13%
1,749
-17
-1% -$5.03K
TEVA icon
43
Teva Pharmaceuticals
TEVA
$43.6B
$464K 0.11%
8,064
-2,200
-21% -$128K
BRK.A icon
44
Berkshire Hathaway Class A
BRK.A
$1.08T
$452K 0.11%
200
– –
KRFT
45
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$446K 0.11%
7,110
-800
-10% -$52.8K
DD icon
46
DuPont de Nemours
DD
$18.6B
$403K 0.1%
3,485
-592
-15% -$70.3K
MDLZ icon
47
Mondelez International
MDLZ
$80.5B
$395K 0.09%
10,882
– –
CVX icon
48
Chevron
CVX
$394B
$393K 0.09%
3,500
– –
ADP icon
49
Automatic Data Processing
ADP
$112B
$349K 0.08%
4,185
– –
AXP icon
50
American Express
AXP
$227B
$342K 0.08%
3,675
– –
1
2
3

Similar funds

MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
PRC
Pearl River Capital Niles, Michigan $630M AUM 17.08% 1-Year Est. Return
SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return
TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return

Greylin Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, Greylin Investment Management held 64 positions worth $420M, down 1% from $424M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Greylin Investment Management's Q1 2015 filing shows 2 new, 1 increased, 25 reduced and 2 closed positions. Its largest new stake was GSK: 17,764 shares worth $949K. The largest sale was Chesapeake Energy Corporation, an estimated $904K.

By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 38% a quarter earlier, followed by Energy and Healthcare.

  • Greylin Investment Management's largest Q1 2015 buy was GSK: 17,764 shares worth $949K.
  • Greylin Investment Management added most to Pfizer in Q1 2015, an estimated $3.34K increase.
  • Greylin Investment Management's biggest Q1 2015 reduction was Chesapeake Energy Corporation, cutting an estimated $904K.
  • Greylin Investment Management fully exited Altria Group in Q1 2015, selling an estimated $281K.
  • Greylin Investment Management's ten largest holdings make up 77% of its $420M portfolio in Q1 2015.
  • Greylin Investment Management opened 2 new positions and closed 2 in Q1 2015.
  • Greylin Investment Management's portfolio value fell 1% quarter-over-quarter to $420M.

Based on Greylin Investment Management's 13F filing for Q1 2015, filed 17 Apr 2015.